Purchase Order 75N92020P00274

Award Date 9/18/20
Potential Completion Date 8/14/24
Potential Value $803K
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95131, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $764,203.60 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Becton, Dickinson & Co (BD), a large medical technology manufacturer. The contract is for a Becton Dickinson FACSymphony S6 cell sorter, which is a specialized flow cytometry instrument used for advanced medical research and clinical laboratory applications. The contract has a completion date of September 29, 2025. There is no...
This is a $664,873.38 firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency within the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a SYMPHONY S6 CELL SORTER. The contract does not have a set-aside designation, indicating BD competed for this award on an unrestricted basis. BD, a large medical technology manufacturer, specializes in flow cytometry, cell imaging, and genomics instruments...
This is a $2,109,663.75 firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Becton, Dickinson And Company (BD). The contract is for the procurement of three FacSymphony S6 Flow Cytometry Cell Sorter systems from BD Biosciences, a division of BD, to increase the cell sorting capabilities of the NIAID Vaccine Research Center Flow Cytometry Core Facility....
This is a $148,932.00 firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) through its BDB Division and BD Biosciences brand. The contract is for maintenance of a BD FACSAria Fusion 5 Laser System, a specialized flow cytometry instrument used for biomedical research and clinical applications. The award resulted from a competitive...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Becton, Dickinson And Company (BD), a global medical technology manufacturer, for a service agreement to provide a Facsaria Fusion SORP flow cytometry system with Rhapsody and OBIS laser accessories. The award has a potential value of $163,080.00 and a completion date of January 4, 2024. This purchase order is not set aside...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, to Becton, Dickinson and Company (BD) for the upgrade of a BD FACSARIA II ACDU flow cytometry instrument. The contract has a ceiling value of $38,460.00 and an ultimate completion date of August 3, 2016. This award was not set aside for any specific business category. BD is a global medical technology company that...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $73,666.80 firm fixed price purchase order to Becton, Dickinson and Company (BD) for a service contract to provide a FACSymphony S6 cell sorter and 5 various lasers. This contract does not have a set-aside designation. BD is a global medical technology company that develops, manufactures, and sells medical supplies, instruments, laboratory equipment, and diagnostic products. The company has extensive experience...
This is a $86,575.68 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for service and maintenance on a BD A1 Symphony flow cytometry instrument. The contract has a term of approximately 4 years, with a completion date of June 12, 2028. BD, through its BDB Division and BD Biosciences brand, is a global medical technology company that specializes in flow cytometry and...
This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for a service agreement to provide a FACSMelody cell sorter. The contract has a ceiling value of $16,092 and a completion date of December 19, 2022. This award is not associated with a set-aside program. BD is a global medical technology company that provides specialized instruments,...
The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $185,925.88 firm fixed-price purchase order to Becton, Dickinson and Company (BD) for a high throughput flow cytometer analyzer. The order has an October 31, 2022 completion date. BD, a global medical technology company, provides instruments, reagents, and services that support biomedical research and clinical applications through its BD Biosciences division. This award is not...

This is a $803,312.50 firm fixed-price purchase order awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Becton, Dickinson and Company (BD) to provide a flow cytometry cell sorter equivalent to the FACSymphony S6. The contract has no set-aside designation and has an ultimate completion date of August 14, 2024. BD, a global medical technology manufacturer, has extensive experience providing specialized biomedical research equipment and consumables to various federal agencies through prime contracts and subcontracts. This award likely supports NIAMS biomedical research programs leveraging advanced cell analysis technologies.

Generated 9/7/24, 11:24 AM